Currently it only shows your basic business info. Start adding relevant business details such as description, images and products or services to gain your customers attention by using Boost 360
android app
/
iOS App/ web portal.
{
"products": [
{
"_id": "6a460bf90c11f3c74a816c87",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "methylprednisolone sodium succinate for injection usp",
"description": "Methylprednisolone Sodium Succinate for Injection USP is a fast-acting corticosteroid administered intravenously or intramuscularly to control severe inflammation, allergic reactions, and autoimmune flare-ups. It works by rapidly suppressing the immune and inflammatory response and is used in hospital or clinical settings for acute conditions such as severe asthma attacks, anaphylaxis, autoimmune disease flares, and spinal cord injury protocols. It is a Schedule H prescription drug administered only under medical supervision.\n\nWhat Is Methylprednisolone Sodium Succinate for Injection USP?\n\nMethylprednisolone Sodium Succinate for Injection USP is a water-soluble, injectable corticosteroid used for rapid control of severe inflammatory, allergic, and autoimmune conditions. It is manufactured to United States Pharmacopeia (USP) standards and is typically administered by a healthcare professional via intravenous (IV) or intramuscular (IM) route when fast, high-potency anti-inflammatory or immunosuppressive action is required — situations where oral steroids act too slowly or oral intake isn't feasible.\n\nHow It Works\n\nMethylprednisolone sodium succinate is a synthetic glucocorticoid that acts rapidly once reconstituted and injected.\n\n\nBinds glucocorticoid receptors – enters cells and binds intracellular receptors that regulate inflammatory gene expression.\nSuppresses inflammatory mediators – reduces production of prostaglandins, leukotrienes, and cytokines responsible for swelling, redness, and pain.\nStabilizes cell membranes – reduces capillary permeability, limiting fluid leakage and tissue swelling at the site of inflammation.\nDampens immune overactivity – suppresses lymphocyte and macrophage activity, calming autoimmune or allergic overreactions.\nDelivers rapid systemic action – because it's water-soluble and given IV/IM, onset of anti-inflammatory effect is significantly faster than oral steroids.\n\n\nClinical Indications\n\nConditionWhy Methylprednisolone Injection Is UsedSevere Allergic Reactions / AnaphylaxisRapidly controls swelling, airway inflammation, and allergic cascadeAcute Asthma Exacerbation / COPD FlareReduces airway inflammation when inhalers alone are insufficientAutoimmune Disease Flares (Lupus, Rheumatoid Arthritis)High-dose pulse therapy to control acute flaresSpinal Cord Injury (acute, under specialist protocol)Used in specific clinical protocols to limit secondary inflammationSevere Dermatologic ReactionsControls widespread inflammatory skin reactionsPost-Transplant / Organ Rejection ManagementUsed as part of immunosuppressive regimens\n\nDosage & Administration\n\nParameterRecommendationTypical Adult Dose10–40 mg IV, may range up to 30 mg/kg in high-dose pulse therapy for specific conditionsRouteIntravenous (IV) injection/infusion or Intramuscular (IM) injectionFrequencyAs directed by the treating physician; often single dose or short tapering courseReconstitutionMust be reconstituted only with the accompanying diluent as per product insert, immediately before useAdministration SettingHospital, clinic, or under direct medical/nursing supervision onlyDurationShort-term acute use unless otherwise directed; long-term use requires specialist monitoring\n\nThis is a Schedule H prescription-only medicine. Dosage must be determined and administered by a qualified healthcare professional.\n\nPrecautions\n\n\nTo be administered only by or under the supervision of a healthcare professional.\nNot for self-administration or home use.\nInform the doctor of any active infections, as corticosteroids can mask symptoms and suppress immune response.\nUse with caution in patients with diabetes, hypertension, peptic ulcer disease, osteoporosis, or psychiatric history.\nAvoid live vaccines during treatment due to immunosuppressive effects.\nPregnant or breastfeeding patients should use only under strict medical guidance.\nAbrupt discontinuation after prolonged use should be avoided; tapering may be required as advised by the physician.\n\n\nPossible Side Effects\n\nMost side effects relate to the drug's systemic corticosteroid action and are monitored by the administering clinician:\n\n\nElevated blood sugar levels\nFluid retention, increased blood pressure\nMood changes, insomnia, or restlessness\nNausea or gastrointestinal discomfort\nIncreased susceptibility to infection\nInjection site reactions\n\n\nSerious side effects requiring immediate medical attention include severe allergic reaction, signs of infection (fever, chills), significant mood or behavioral changes, unusual swelling, or vision disturbances. Because this is administered in a clinical setting, the healthcare team monitors for these actively.\n\nComparison: Methylprednisolone vs. Other Injectable Corticosteroids\n\nDrugRelative PotencyCommon Use CaseRouteMethylprednisolone Sodium SuccinateHighAcute severe inflammation, autoimmune flaresIV/IMHydrocortisone Sodium SuccinateLowerAdrenal insufficiency, milder acute inflammationIV/IMDexamethasone Sodium PhosphateVery HighCerebral edema, severe allergic/inflammatory conditionsIV/IMBetamethasone Sodium PhosphateHighAllergic and inflammatory conditions, fetal lung maturityIV/IMTriamcinolone AcetonideModerate (depot)Localized/intra-articular inflammationIM/Intra-articular\n\nKey Statistics\n\nStatisticData PointSourceOnset of anti-inflammatory action after IV administrationWithin 1–2 hours for measurable effectClinical pharmacology references, USP monographUse in acute severe asthma protocolsRecommended as part of systemic corticosteroid therapy in emergency guidelinesGlobal Initiative for Asthma (GINA) guidelinesHospital use in anaphylaxis managementIncluded as an adjunct in anaphylaxis treatment protocols alongside epinephrineWorld Allergy Organization guidanceHigh-dose pulse therapy applicationUsed in select autoimmune flare protocols under specialist supervisionPublished rheumatology treatment guidelines\n\nExpert Insight\n\n[Insert verified physician or clinical pharmacologist commentary here — Claude has not fabricated a quote. Recommend sourcing a short, attributable statement from a Steris Healthcare medical advisor or a cited clinical guideline before publishing.]\n\nConclusion\n\nMethylprednisolone Sodium Succinate for Injection USP is a high-potency, fast-acting corticosteroid reserved for situations where rapid control of severe inflammation, allergic reaction, or autoimmune flare is essential. Administered only under clinical supervision, it plays a critical role in emergency and hospital-based treatment protocols — from anaphylaxis and acute asthma to autoimmune disease management. As a Schedule H medicine, it must never be self-administered; dosage, route, and duration should always be determined by a qualified physician based on the patient's condition. For pharmacopoeia-grade quality and reliable hospital supply, source this injection through a WHO-GMP certified manufacturer.\n\nPrescription only – consult your doctor.\n\n\nHigh-Ranking FAQs (Google Search & Voice Search Optimized)\n\n1. What is methylprednisolone sodium succinate injection used for?\nIt is used to rapidly control severe inflammation, allergic reactions, and autoimmune flare-ups, such as anaphylaxis, acute asthma attacks, and lupus or rheumatoid arthritis flares. It is administered under medical supervision in hospital or clinical settings.\n\n2. Is methylprednisolone injection a steroid?\nYes, it is a synthetic corticosteroid (glucocorticoid) that works by suppressing inflammatory and immune responses in the body, providing rapid relief in acute, severe conditions.\n\n3. How is methylprednisolone sodium succinate injection given?\nIt is given by a healthcare professional via intravenous (IV) or intramuscular (IM) injection, after being reconstituted with the correct diluent immediately before administration. It is not for self-injection or home use.\n\n4. How fast does methylprednisolone injection start working?\nBecause it is water-soluble and given directly into the bloodstream or muscle, measurable anti-inflammatory effects typically begin within one to two hours of administration.\n\n5. What are the side effects of methylprednisolone injection?\nCommon effects include elevated blood sugar, fluid retention, mood changes, and increased infection risk. These are monitored by the administering healthcare team, and serious reactions are managed promptly in a clinical setting.\n\n6. Is methylprednisolone sodium succinate injection available without a prescription?\nNo. It is a Schedule H prescription-only medicine that must be administered by or under the direct supervision of a qualified healthcare professional.\n\n7. What is the difference between methylprednisolone and dexamethasone injection?\nBoth are injectable corticosteroids, but dexamethasone has a longer duration of action and higher relative potency, while methylprednisolone is often preferred for acute pulse therapy and shorter-acting systemic control. The choice depends on the clinical scenario and physician judgment.\n\n8. Can methylprednisolone injection be used in pregnancy?\nIt may be used in pregnancy only when clearly necessary and under strict medical supervision, as the treating physician will weigh the benefits against potential risks for the specific condition being treated.",
"price": 47.0,
"discountamount": 19.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2465,
"imageuri": "https://productimages.withfloats.com/actual/6a460bfb9f5529389b8b15b8.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6a460bfb9f5529389b8b15b8.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-07-02T06:58:01.631Z",
"updatedon": "2026-07-02T06:58:01.631Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/methylprednisolone-sodium-succinate-for-injection-usp/2465",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "METHIDENOSOLE 40 INJ",
"category": "GENERAL RANGE",
"tags": [
"methylprednisolone sodium succinate injection uses",
"methylprednisolone sodium succinate injection uses in hindi",
"methylprednisolone sodium succinate",
"methylprednisolone sodium succinate injection",
"inj methylprednisolone sodium succinate",
"methylprednisolone sodium succinate uses in hindi",
"methylprednisolone sodium succinate for injection",
"methylprednisolone sodium succinate injection usp"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "69e8bb02806295e2dbefc5e3",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "risedronate sodium tablets ip 35 mg",
"description": "Risedronate Sodium Tablets IP 35 mg\n\nMaintaining strong and healthy bones becomes increasingly important with age, especially for individuals at risk of osteoporosis or bone loss. Risedronate Sodium Tablets IP 35 mg is a clinically proven medication widely prescribed to strengthen bones, reduce fracture risk, and improve overall skeletal health. If you are considering this treatment, this buyer-focused guide will help you understand everything—from how it works to its benefits, dosage, precautions, and what to check before purchasing.\n\nWhat are Risedronate Sodium Tablets IP 35 mg?\n\nRisedronate Sodium Tablets IP 35 mg contains risedronate sodium, a medication that belongs to a class called bisphosphonates. These drugs are specifically designed to prevent bone breakdown and increase bone density.\n\nIt is commonly used to treat and prevent the following:\n\nOsteoporosis in postmenopausal women\nOsteoporosis in men\nBone loss due to long-term steroid use\nPaget’s disease of bone\n\nThis once-weekly dosage (35 mg) is convenient and effective for long-term bone health management.\n\nHow Do Risedronate Sodium Tablets IP 35 mg Work?\n\nBones are constantly being renewed through a process called bone remodeling, where old bone is broken down and new bone is formed. In conditions like osteoporosis, bone breakdown occurs faster than formation, leading to weak and fragile bones.\n\nMechanism of Action:\nRisedronate inhibits osteoclasts (cells responsible for bone breakdown)\nSlows down bone loss\nHelps maintain or increase bone density\nReduces the risk of fractures, especially in the spine and hips\n\nBy restoring balance in bone remodeling, this medication strengthens bones over time.\n\nKey Benefits of Risedronate Sodium Tablets IP 35 mg\n1. Strengthens Bones\n\nHelps increase bone mineral density, making bones stronger and less prone to fractures.\n\n2. Reduces Fracture Risk\n\nSignificantly lowers the risk of spine, hip, and other bone fractures.\n\n3. Convenient Weekly Dosage\n\nThe 35 mg tablet is typically taken once a week, improving patient compliance.\n\n4. Effective for Long-Term Use\n\nSuitable for ongoing treatment under medical supervision.\n\n5. Proven Clinical Safety\n\nWidely used and trusted by healthcare professionals worldwide.\n\nWho Should Consider Buying Risedronate Sodium Tablets IP 35 mg?\n\nThis medication is suitable for:\n\nPostmenopausal women at risk of osteoporosis\nMen diagnosed with low bone density\nPatients on long-term corticosteroid therapy\nIndividuals with a history of fractures due to weak bones\nPatients diagnosed with Paget’s disease\n\nImportant: Always consult a healthcare professional before starting this medication.\n\nDosage and Administration\n\nProper usage is crucial to ensure effectiveness and reduce side effects.\n\nGeneral Guidelines:\nUsually taken once weekly (same day each week)\nTake the tablet first thing in the morning\nSwallow with a full glass of plain water (not juice or milk)\nTake on an empty stomach\nImportant Instructions:\nDo not lie down for at least 30 minutes after taking the tablet\nAvoid eating or drinking anything else for 30 minutes\nDo not crush or chew the tablet\n\nFollowing these instructions helps prevent irritation of the esophagus and improves absorption.\n\nPossible Side Effects\n\nLike all medications, Risedronate Sodium Tablets IP 35 mg may cause side effects.\n\nCommon Side Effects:\nStomach pain\nIndigestion\nNausea\nJoint or muscle pain\nLess Common but Serious Side Effects:\nDifficulty swallowing\nSevere chest pain\nJaw pain (rare, associated with osteonecrosis)\nUnusual thigh bone fractures (rare)\n\nIf you experience severe or persistent symptoms, seek medical attention immediately.\n\nPrecautions and Warnings\n\nBefore using this medication, consider the following:\n\nMedical Conditions:\nInform your doctor if you have esophageal disorders\nPatients with kidney problems should use caution\nLow calcium levels should be corrected before starting treatment\nPregnancy and Breastfeeding:\nNot recommended unless prescribed\nConsult your doctor for guidance\nDrug Interactions:\n\nRisedronate may interact with the following:\n\nCalcium supplements\nAntacids\nIron supplements\n\nThese should be taken at a different time of day to avoid interference with absorption.\n\nStorage Instructions\n\nTo maintain the quality of the medication:\n\nStore in a cool, dry place\nKeep away from moisture and sunlight\nMaintain temperature below 25°C\nKeep out of reach of children\nBuying Guide: What to Check Before Purchase\n\nWhen purchasing Risedronate Sodium Tablets IP 35 mg, ensure the following:\n\nIt is prescribed by a qualified doctor\nThe product is from a reputable pharmaceutical brand\nPackaging is intact and properly sealed\nExpiry date is valid\nPurchased from a licensed pharmacy\n\nBulk buyers and distributors should source from trusted suppliers to ensure consistent quality and authenticity.\n\nWhy Choose Risedronate Sodium Tablets IP 35 mg?\n\nThis medication stands out due to:\n\nProven effectiveness in improving bone health\nConvenient once-weekly dosing\nReduced risk of fractures\nLong-term safety when monitored\nCost-effective treatment option\n\nFor individuals seeking reliable osteoporosis management, this tablet offers a practical and effective solution.\n\nFrequently Asked Questions (FAQs)\n1. How long does it take to see results?\n\nBone improvement may take several months, but fracture risk reduction begins earlier.\n\n2. Can I take it daily?\n\nNo, the 35 mg dose is typically taken once weekly.\n\n3. Is it safe for long-term use?\n\nYes, under medical supervision with regular monitoring.\n\n4. Can I take it with food?\n\nNo, it should be taken on an empty stomach for proper absorption.\n\n5. Do I need supplements with this medication?\n\nDoctors often recommend calcium and vitamin D supplements alongside treatment.\n\nLifestyle Tips for Better Bone Health\n\nTo maximize the benefits of Risedronate Sodium Tablets IP 35 mg:\n\nMaintain a calcium-rich diet\nEnsure adequate vitamin D intake\nEngage in weight-bearing exercises\nAvoid smoking and excessive alcohol consumption\nGet regular bone density tests\nConclusion\n\nRisedronate Sodium Tablets IP 35 mg is a trusted and effective solution for managing osteoporosis and improving bone strength. With its proven ability to reduce fracture risk and enhance bone density, it plays a vital role in long-term skeletal health.\n\nFor best results, follow your doctor’s instructions carefully, maintain a healthy lifestyle, and ensure regular medical check-ups. Choosing the right treatment today can significantly improve your bone health and overall quality of life in the future.",
"price": 421.0,
"discountamount": 127.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2387,
"imageuri": "https://productimages.withfloats.com/actual/69e8bb084671736d8a47c29c.png",
"tileimageuri": "https://productimages.withfloats.com/tile/69e8bb084671736d8a47c29c.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-04-22T12:11:46.043Z",
"updatedon": "2026-04-23T06:25:36.613Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//risedronate-sodium-tablets-ip-35-mg/2387",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "RISONDROS 35",
"category": "ORTHOLOGYRANG",
"tags": [
"risedronate sodium tablets ip 35 mg",
"risedronate sodium tablets ip 35 mg uses in hindi"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "66e167c58d6e7f6326a9f8c0",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Aqoa/DM Water/ EUA. Ethyl Butylacetylaminoproionate , Cetearyl Alochol and Ceteareth -20 , Caprvlic Capric Triglyceride ,Glycerol Monosterate , Butyrospermum Parkii (Shea) Butter , Glycerin , Xylityglucoside (and) Anhydroxylitol (and) Xylitol , Vitamin E Acetate , Phenoxyethanol (and) Ethylhexylglycerin , Perfume , Disodium EDTA",
"description": "EUROSOFT MOSQUITO SHIELD is a cutting-edge mosquito repellent lotion designed to provide effective, long-lasting protection against mosquitoes. Formulated with powerful and skin-friendly ingredients, it not only protects from insect bites but also nourishes and moisturizes the skin. Suitable for all skin types, this product ensures a safe and comfortable outdoor experience without the worry of mosquito bites.\n\nKey Ingredients:\n \nAqoa/DM Water/ EUA: Acts as the base for the formula, providing hydration and smooth application.\nEthyl Butylacetylaminoproionate: A highly effective mosquito repellent agent known for its ability to repel mosquitoes for extended periods.\nCetearyl Alcohol and Ceteareth-20: Emollients that help in smooth application and maintain skin’s moisture balance.\nCaprylic/Capric Triglyceride: A skin-conditioning agent that helps in maintaining softness and smoothness.\nGlycerol Monostearate: An emulsifying agent that prevents separation of ingredients, ensuring consistent application.\nButyrospermum Parkii (Shea) Butter: Provides deep moisturization, soothing dry skin and enhancing skin barrier function.\nGlycerin: A humectant that draws moisture into the skin, keeping it hydrated.\nXylityglucoside, Anhydroxylitol, Xylitol: Skin-conditioning agents that enhance the hydration levels and improve skin texture.\nVitamin E Acetate: A potent antioxidant that protects the skin from damage while promoting skin healing.\nPhenoxyethanol and Ethylhexylglycerin: Mild preservatives that prevent the growth of harmful microorganisms in the product.\nPerfume: Provides a pleasant scent without overpowering.\nDisodium EDTA: A stabilizing agent that enhances the effectiveness of the formula by binding to metals.\n \n\nKey Benefits:\n \n\nLong-Lasting Mosquito Protection: The active ingredient, Ethyl Butylacetylaminoproionate, ensures hours of protection from mosquitoes, allowing users to enjoy outdoor activities worry-free.\nHydrating and Nourishing: With ingredients like Shea Butter and Glycerin, the product provides deep hydration, keeping the skin soft and moisturized.\nGentle on Skin: Formulated with skin-friendly ingredients, EUROSOFT MOSQUITO SHIELD is suitable for all skin types, including sensitive skin.\nNon-Greasy: Thanks to the presence of lightweight emollients like Caprylic/Capric Triglyceride, the lotion absorbs quickly without leaving a greasy residue.\nAntioxidant Protection: Enriched with Vitamin E, the lotion not only protects from mosquitoes but also shields the skin from environmental damage.\nPleasant Scent: Infused with a mild perfume, the lotion leaves a refreshing fragrance that enhances the user experience.\n \n\nHow Does It Work?\n\nEUROSOFT MOSQUITO SHIELD works by creating a protective barrier on the skin, repelling mosquitoes effectively. The active ingredient, Ethyl Butylacetylaminoproionate, is a potent mosquito repellent that disrupts the mosquito’s ability to sense its host, preventing bites. Additionally, ingredients like Cetearyl Alcohol and Ceteareth-20 ensure that the lotion spreads evenly across the skin, forming a uniform shield that lasts for hours. With added moisturizing and antioxidant benefits, it keeps the skin hydrated and protected.\n\n \n\nDirections for Use:\n \nApply an even layer of EUROSOFT MOSQUITO SHIELD to all exposed areas of skin before outdoor activities.\nReapply as needed, especially after excessive sweating or swimming.\nAvoid applying directly to the face. Instead, apply the lotion to your hands first and gently pat it onto the face.\nFor children, apply to an adult’s hands first, then spread evenly on the child’s skin, avoiding the hands and eyes.\n \n\nSide Effects:\n\nEUROSOFT MOSQUITO SHIELD is formulated to be gentle and suitable for all skin types. However, some individuals may experience mild skin irritation or allergic reactions. If irritation occurs, discontinue use and consult a healthcare professional. Avoid contact with eyes, and do not ingest. Keep out of reach of children.\n\n ",
"price": 295.0,
"discountamount": 88.5,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 7,
"_keywords": [
"dry skin",
"skin types",
"Shea Butter",
"skin healing",
"skin texture",
"mild perfume",
"insect bites",
"Side Effects",
"Key Benefits",
"exposed areas",
"Disodium EDTA",
"sensitive skin",
"deep hydration",
"greasy residue",
"pleasant scent",
"mosquito bites",
"uniform shield",
"Key Ingredients",
"user experience",
"moisture balance",
"hydration levels",
"Cetearyl Alcohol",
"extended periods",
"Cetearyl Alochol",
"active ingredient",
"stabilizing agent",
"emulsifying agent",
"Vitamin E Acetate",
"allergic reactions",
"excessive sweating",
"smooth application",
"outdoor activities",
"Mild preservatives",
"protective barrier",
"potent antioxidant",
"Aqoa/DM Water/ EUA",
"deep moisturization",
"environmental damage",
"antioxidant benefits",
"refreshing fragrance",
"Butyrospermum Parkii",
"Glycerol Monosterate",
"mild skin irritation",
"Glycerol Monostearate",
"skin barrier function",
"lightweight emollients",
"harmful microorganisms",
"consistent application",
"Antioxidant Protection",
"healthcare professional",
"skin-conditioning agent",
"EUROSOFT MOSQUITO SHIELD",
"skin-friendly ingredients",
"potent mosquito repellent",
"Caprylic/Capric Triglyceride",
"Caprvlic Capric Triglyceride",
"comfortable outdoor experience",
"Ethyl Butylacetylaminoproionate",
"Long-Lasting Mosquito Protection",
"effective, long-lasting protection",
"effective mosquito repellent agent",
"cutting-edge mosquito repellent lotion"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 1974,
"imageuri": "https://productimages.withfloats.com/actual/66e167c7e959b47a07e3c817.png",
"tileimageuri": "https://productimages.withfloats.com/tile/66e167c7e959b47a07e3c817.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-09-11T09:49:57.33Z",
"updatedon": "2026-03-12T09:20:29.386Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//aqoa-dm-water-eua-ethyl-butylacetylaminoproionate-cetearyl-alochol-and-ceteareth-20-caprvlic-capric-triglyceride-glycerol-monosterate-butyrospermum-parkii-shea-butter-glycerin-xylityglucoside-and-anhydroxylitol-and-xylitol-vitamin-e-acetate-phenoxyethanol-and-ethylhexylglycerin-perfume-disodium-edta/1974",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "EUROSOFT MOSQUITO SHIELD",
"category": "Dermatology",
"tags": [
"Eurosoft mosquito review",
"Eurosoft mosquito sale",
"Eurosoft mosquito shield amazon",
"Eurosoft mosquito shield review",
"protection against mosquitoes",
"mosquito bites.",
"mosquitoes, allowing users to enjoy outdoor activities worry-free"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": "",
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.001,
"isnotforsale": false
},
{
"_id": "66d8476af04988d5cb82649f",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "phenytoin sodium 300mg",
"description": "\nPhenytoin Sodium 300mg is a widely prescribed antiepileptic medicine used to help control seizures and support neurological stability. If you are searching for an effective treatment for epilepsy, seizure disorders, or related conditions, Phenytoin Sodium 300mg is commonly recommended by healthcare professionals for long-term management under medical supervision.\n\nSeizures can affect daily life, confidence, and overall health. Proper treatment with Phenytoin Sodium 300mg can help reduce seizure frequency, support better control, and improve quality of life when taken regularly as prescribed.\n\nWhat is phenytoin sodium 300 mg?\n\nPhenytoin Sodium 300mg is an anticonvulsant medicine used to prevent and control certain types of seizures. It works by stabilizing electrical activity in the brain and reducing abnormal nerve signals that may trigger seizures.\n\nIt is commonly used in epilepsy care and may also be prescribed in selected neurological conditions based on doctor advice.\n\nHow Does Phenytoin Sodium 300mg Work?\n\nThe brain communicates through electrical signals. In epilepsy or seizure disorders, sudden abnormal electrical activity can lead to seizures.\n\nPhenytoin Sodium 300mg works by slowing excessive nerve impulses and stabilizing brain activity. This helps prevent uncontrolled electrical firing that can cause seizures.\n\nAs a result, patients may experience improved seizure control and greater day-to-day confidence.\n\nUses of Phenytoin Sodium 300mg\n\nDoctors may prescribe Phenytoin Sodium 300mg for several conditions.\n\n1. Epilepsy Management\n\nUsed to prevent and control certain seizure types.\n\n2. Generalized Tonic-Clonic Seizures\n\nCommonly prescribed for selected seizure disorders.\n\n3. Partial Seizures\n\nMay be recommended for focal seizure control.\n\n4. Post-Surgical Seizure Prevention\n\nSometimes used in hospital settings under supervision.\n\n5. Long-Term Seizure Control\n\nOften used as part of ongoing epilepsy treatment plans.\n\nKey Benefits of Phenytoin Sodium 300mg\n\nChoosing phenytoin sodium 300 mg offers several benefits.\n\nHelps Control Seizures\n\nSupports prevention of recurring seizure episodes.\n\nStabilizes Brain Activity\n\nHelps regulate abnormal electrical signals.\n\nSupports Better Quality of Life\n\nReduced seizures may improve daily independence.\n\nTrusted Neurology Treatment\n\nWidely used for many years in seizure management.\n\nLong-Term Management Option\n\nOften suitable for continued use under doctor guidance.\n\nWho May Need Phenytoin Sodium 300 mg?\n\nYour healthcare provider may prescribe Phenytoin Sodium 300mg if you have:\n\nDiagnosed epilepsy\nRecurrent seizures\nFocal seizures\nTonic-clonic seizures\nNeed seizure prevention after specific medical procedures\nNeurological conditions requiring anticonvulsant therapy\n\nOnly take this medicine after a professional diagnosis.\n\nHow to Take Phenytoin Sodium 300mg\n\nAlways use Phenytoin Sodium 300mg exactly as directed by your doctor.\n\nGeneral Directions:\nTake with water\nTake at the same time each day\nCan be taken with food if advised\nSwallow as instructed\nDo not skip doses\nDo not stop suddenly without medical advice\n\nConsistency is very important for seizure control.\n\nDosage Information\n\nPhenytoin Sodium 300mg dosage depends on:\n\nAge\nWeight\nSeizure type\nMedical history\nBlood level monitoring\nResponse to treatment\n\nNever increase or reduce the dose on your own.\n\nCommon Side Effects of Phenytoin Sodium 300mg\n\nSome people may experience mild side effects, especially during early treatment.\n\nCommon Side Effects:\nDizziness\nDrowsiness\nNausea\nHeadache\nUnsteady movement\nMild confusion\nGum swelling\nFatigue\n\nInform your doctor if symptoms persist.\n\nSerious Side Effects\n\nSeek immediate medical care if you notice:\n\nSevere rash\nFever\nUnusual bruising\nYellowing of skin or eyes\nSevere balance problems\nMood changes\nVision problems\nDifficulty speaking\n\nPrompt medical review is important.\n\nImportant Precautions\n\nBefore using Phenytoin Sodium 300mg, tell your doctor if you have:\n\nLiver disease\nKidney problems\nHeart conditions\nDiabetes\nDepression or mood disorders\nPregnancy or planning pregnancy\nHistory of allergies to anticonvulsants\nOther chronic illnesses\n\nRegular follow-up may be required.\n\nDrug Interactions\n\nPhenytoin Sodium 300mg may interact with several medicines.\n\nTell your doctor if you take:\n\nOther seizure medicines\nBlood thinners\nAntibiotics\nAntifungal medicines\nHormonal contraceptives\nVitamins or herbal supplements\nAlcohol or sedatives\n\nProfessional monitoring helps maintain safety.\n\nPhenytoin Sodium 300mg in Pregnancy\n\nUse during pregnancy only under medical supervision. Seizure control is important, but treatment decisions require specialist guidance.\n\nNever stop anticonvulsant therapy suddenly during pregnancy without consulting your doctor.\n\nStorage Instructions\n\nStore properly:\n\nKeep in a cool, dry place\nProtect from sunlight and moisture\nKeep away from children\nDo not use expired medicine\nWhy Buy Phenytoin Sodium 300mg?\n\nIf you need dependable seizure management support, Phenytoin Sodium 300mg is a trusted choice because it offers:\n\nEffective seizure control support\nLong-standing medical use\nNeurological stability assistance\nDoctor-recommended therapy\nSuitable long-term management option\nTips for Better Seizure Management\n\nAlong with medication:\n\nTake medicine regularly\nGet adequate sleep\nAvoid missing doses\nLimit alcohol if advised\nManage stress levels\nKeep follow-up appointments\nTrack seizure patterns\nInform doctor about side effects\nFrequently Asked Questions\nIs phenytoin sodium 300 mg used for epilepsy?\n\nYes, it is commonly prescribed to help control seizures.\n\nCan I stop when seizures improve?\n\nNo. Sudden stopping may increase seizure risk. Only stop under doctor's guidance.\n\nIs daily use necessary?\n\nYes, regular dosing is important for stable blood levels.\n\nDoes it cause drowsiness?\n\nSome people may feel dizziness or drowsiness, especially initially.\n\nIs monitoring required?\n\nYes, doctors may recommend blood tests and regular reviews.\n\nWhy Purchase from a Trusted Supplier?\n\nAlways buy Phenytoin Sodium 300mg from a reliable pharmacy or supplier to ensure the following:\n\nGenuine medicine quality\nCorrect storage conditions\nProper packaging\nAuthentic product supply\nSafe dispensing standards\nConclusion\n\nPhenytoin Sodium 300mg is a trusted anti-epileptic medicine used to control seizures and support long-term neurological health. By stabilizing abnormal electrical activity in the brain, it helps reduce seizure frequency and improve daily confidence when taken consistently under medical supervision.\n",
"price": 139.0,
"discountamount": 42.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 7,
"_keywords": [
"same time",
"mood swings",
"Key Benefits",
"nerve activity",
"manic episodes",
"household spoon",
"different types",
"potent solution",
"incorrect dosing",
"migraine attacks",
"efficient relief",
"bipolar disorder",
"Phenytoin Sodium",
"Divalproex Sodium",
"Fine hand tremors",
"Mood Stabilization",
"migraine headaches",
"oral solution form",
"dosage instructions",
"Easy Administration",
"healthcare provider",
"electrical activity",
"effective treatment",
"Common side effects",
"temporary hair loss",
"Migraine Prophylaxis",
"significant benefits",
"various neurological",
"psychiatric conditions",
"subsequent weight gain",
"gamma-aminobutyric acid",
"abnormal brain activity",
"proper measuring device",
"Effective Seizure Control",
"gastrointestinal discomfort",
"DIOWELPREX 250 Oral Solution"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 1965,
"imageuri": "https://productimages.withfloats.com/actual/69f47bd3a470ba2127cd4596.png",
"tileimageuri": "https://productimages.withfloats.com/tile/69f47bd3a470ba2127cd4596.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-09-04T11:41:30.55Z",
"updatedon": "2026-05-01T10:09:22.918Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//phenytoin-sodium-300mg/1965",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "STERITOIN 300 ",
"category": "NEUROLOGY RANGE",
"tags": [
"phenytoin sodium 300mg",
"Phenytoin Sodium 300mg price in India",
"Buy Phenytoin Sodium 300mg online",
"Generic Phenytoin Sodium 300mg tablets",
"Phenytoin Sodium 300mg manufacturer India",
"Affordable Phenytoin Sodium 300mg tablets",
"Best Phenytoin Sodium 300mg brand"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": "",
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.001,
"isnotforsale": false
},
{
"_id": "6661a73687f0960e14a2c739",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "mycophenolate sodium 360 mg",
"description": "MYCOPLASM S 360 \nMycophenolate sodium 360 mg is an essential immunosuppressant medication designed to prevent organ transplant rejection, particularly for kidney, heart, and liver transplants. As the sodium salt of mycophenolic acid, it delivers 360 mg of the active moiety per tablet, providing targeted immune suppression to help patients maintain their new organs long-term. This product stands out for its enteric-coated formulation, which enhances gastrointestinal tolerability compared to other forms, making it a preferred choice in post-transplant care regimens.\n\nUses of Mycophenolate Sodium 360 mg\nMycophenolate sodium 360 mg primarily serves as a prophylactic agent against acute rejection in adult and pediatric patients receiving allogeneic renal, cardiac, or hepatic transplants. It works alongside other immunosuppressants like cyclosporine and corticosteroids to create a balanced regimen that minimizes the risk of graft loss. Clinically, it proves effective in de novo transplant recipients, where starting therapy early post-surgery significantly reduces rejection episodes. Beyond transplants, off-label applications include managing refractory autoimmune conditions such as lupus nephritis or myasthenia gravis, where immune overactivity damages tissues.\n\nThe drug targets the proliferation of T- and B-lymphocytes, key players in immune responses that can attack transplanted organs. In renal transplant patients, for instance, it helps preserve kidney function by curbing antibody-mediated rejection. Its role extends to maintenance therapy, where consistent dosing sustains immunosuppression without excessive toxicity. Healthcare providers often adjust it based on patient response and trough levels of the active metabolite, mycophenolic acid (MPA), ensuring optimal therapeutic outcomes.\n\nKey Benefits of Mycophenolate Sodium 360 mg\nMycophenolate sodium 360 mg offers several advantages that make it a cornerstone in transplant medicine. One primary benefit is its selective inhibition of lymphocyte proliferation, sparing other cell types and reducing broad-spectrum immunosuppression risks. This leads to fewer opportunistic infections compared to older agents like azathioprine. The enteric coating minimizes upper GI upset, improving patient compliance—studies show higher adherence rates with this formulation.\n\nEnhanced Graft Survival: Prolongs organ viability by effectively suppressing cell-mediated and humoral immunity, with clinical data showing reduced biopsy-proven rejection rates.\n\nImproved Tolerability: Lower incidence of nausea and diarrhea due to delayed-release technology, allowing twice-daily dosing without food restrictions.\n\nFlexible Dosing: Equivalent to 720 mg mycophenolate mofetil, but with predictable MPA exposure via enterohepatic recirculation for steady-state efficacy.\n\nPediatric Suitability: Approved for children over 2 years in renal transplants, supporting growth without compromising safety.\n\nCost-Effective Long-Term Option: Balances efficacy and side effect profile, potentially lowering overall healthcare costs from fewer rejections or hospitalizations.\n\nPatients experience better quality of life, with sustained energy levels and fewer interruptions from acute rejection crises. Its metabolism to MPA via liver glucuronidation ensures reliable pharmacokinetics, even in patients with mild renal impairment.\n\nSide Effects of Mycophenolate Sodium 360 mg\nWhile highly effective, mycophenolate sodium 360 mg carries risks typical of immunosuppressants, necessitating vigilant monitoring. Common adverse effects stem from its impact on rapidly dividing cells, particularly in the gut and bone marrow.\n\nCommon Side Effects\nGastrointestinal issues like diarrhea, nausea, vomiting, and abdominal pain, affecting up to 30-50% of users.\n\nHeadache, insomnia, and tremor, often mild and transient.\n\nInfections such as urinary tract or respiratory, due to moderated immunity.\n\nHypertension or peripheral edema, manageable with supportive care.\n\nLeukopenia or anemia, requiring periodic blood counts.\n\nSerious Side Effects\nSevere myelosuppression leading to neutropenia or thrombocytopenia, which can increase infection or bleeding risks.\n\nProgressive multifocal leukoencephalopathy (PML), a rare brain infection linked to JC virus reactivation.\n\nGastrointestinal perforation or bleeding, especially in at-risk patients.\n\nIncreased malignancy risk, including lymphoma or skin cancers, over long-term use.\n\nHypersensitivity reactions like rash or anaphylaxis.\n\nRegular complete blood counts, viral monitoring (e.g., CMV, BK virus), and skin exams mitigate these risks. Dose reductions or discontinuation may be needed if counts drop significantly.\n\nMechanism of Action\nMycophenolate sodium 360 mg rapidly hydrolyzes to mycophenolic acid (MPA), a potent, reversible, non-competitive inhibitor of inosine-5'-monophosphate dehydrogenase (IMPDH). This enzyme catalyzes the rate-limiting step in de novo guanine nucleotide synthesis, depleting guanosine nucleotides essential for T- and B-cell DNA replication. Lymphocytes, reliant on this pathway, undergo proliferation arrest, suppressing both cell-mediated immunity and antibody production.\n\nMPA also hinders glycosylation of adhesion molecules on lymphocytes and monocytes, impeding their migration to graft sites. It reduces nitric oxide production in macrophages without affecting endothelial cells, curbing inflammation. Enterohepatic recirculation of the glucuronide metabolite (MPAG) prolongs MPA exposure, enhancing efficacy. Protein binding to albumin (around 97%) ensures targeted delivery, with clearance primarily renal for the inactive form.\n\nDosage and Administration Guidelines\nStandard dosing for renal transplant is 720 mg (two 360 mg tablets) twice daily, starting within 72 hours post-surgery. Adjustments occur for hepatic or cardiac transplants, often alongside cyclosporine. Therapeutic drug monitoring of MPA AUC (area under curve) optimizes levels between 30-60 mcg·h/mL. Take on an empty stomach for best absorption, though food has minimal impact due to the coating.\n\nPrecautions and Warnings\nAvoid in pregnancy (Category D) due to teratogenicity—use contraception and regular pregnancy tests. Contraindicated in active untreated infections. Monitor for GI bleeding in ulcerative colitis patients. Drug interactions with antacids, cholestyramine, or rifampin alter MPA levels. Live vaccines are prohibited.\n\nConclusion\nMycophenolate sodium 360 mg represents a vital advancement in transplant immunosuppression, offering robust protection against rejection with a favorable benefit-risk profile. Its targeted action on lymphocytes, combined with improved GI tolerance, empowers patients to thrive post-transplant. By integrating it into comprehensive regimens with close monitoring, healthcare teams maximize graft success and patient well-being. Always consult a specialist for personalized guidance to harness its full potential safely.\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nORDER Now: \nhttps://www.sterisonline.com/product/mycoplasm-s-360-133670\n\n\n\n\n\n\n",
"price": 767.0,
"discountamount": 567.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 7,
"_keywords": [
"dose",
"risk",
"body",
"part",
"ORDER",
"360mg",
"Email",
"cells",
"dosage",
"nausea",
"vomiting",
"schedule",
"headache",
"strength",
"WhatsApp",
"diarrhea",
"activity",
"rejection",
"treatment",
"infections",
"supplements",
"information",
"MYCOPLASM S",
"sterispharma",
"sterisonline",
"stomach pain",
"blood counts",
"immune system",
"complications",
"liver problems",
"liver function",
"other medications",
"Regular monitoring",
"medical conditions",
"healthcare provider",
"Common side effects",
"Serious side effects",
"white blood cell count",
"potential drug interactions",
"optimal therapeutic effects",
"combination therapy regimen",
"organ transplant recipients",
"Mycophenolate Sodium therapy",
"other immunosuppressive drugs"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 1474,
"imageuri": "https://productimages.withfloats.com/actual/6661a739c749b7962dbc08c6.jpg",
"tileimageuri": "https://productimages.withfloats.com/tile/6661a739c749b7962dbc08c6.jpg",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-06-06T12:10:30.488Z",
"updatedon": "2026-03-12T08:02:36.733Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//mycophenolate-sodium-360-mg/1474",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "MYCOPLASM S 360 ",
"category": "Oncology",
"tags": [
"MYCOPLASM S 360",
"Mycophenolate sodium (360mg)",
"Mycophenolate sodium 360 mg price",
"Mycophenolate sodium 360 mg brands",
"Mycophenolate sodium 360 mg side effects",
"Myfortic 360 alternative",
"Myfortic 500"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": "",
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.001,
"isnotforsale": false
},
{
"_id": "6ad74702e53c888beeab308d",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Empagliozin 10 mg, Sitagliptin 100 mg and Metformin hydrochloride 1000 mg ER Tablets",
"description": "GLIEMPAFLOZIN 3D 10 is a triple-combination antidiabetic tablet containing Empagliflozin 10 mg, Sitagliptin 100 mg, and Metformin Hydrochloride Extended Release (ER) 1000 mg. This combination is intended for the management of type 2 diabetes mellitus in appropriately selected patients under the supervision of a qualified healthcare professional.\n\nThe three active ingredients work through different mechanisms to help regulate blood glucose levels. Empagliflozin helps the kidneys eliminate glucose through urine, Sitagliptin supports glucose-dependent insulin regulation, and Metformin helps reduce glucose production in the liver while improving insulin sensitivity.\n\nBy combining these ingredients in one tablet, GLIEMPAFLOZIN 3D 10 provides a multi-mechanism approach to blood glucose management. Its suitability depends on the patient's clinical condition, kidney function, existing treatment, and the approved prescribing information.\n\nComposition of GLIEMPAFLOZIN 3D 10\nEach tablet contains the following stated active ingredients:\n\nEmpagliflozin 10 mg: A sodium-glucose cotransporter 2 (SGLT2) inhibitor that reduces glucose reabsorption by the kidneys and increases glucose excretion through urine.\nSitagliptin 100 mg: A dipeptidyl peptidase-4 (DPP-4) inhibitor that helps regulate insulin and glucagon responses according to blood glucose levels.\nMetformin Hydrochloride ER 1000 mg: An extended-release biguanide that primarily reduces glucose production in the liver and improves the body's response to insulin.\nThe exact formulation, excipients, approved indications, and administration instructions should be confirmed from the product packaging and official prescribing information.\n\nKey Features of GLIEMPAFLOZIN 3D 10 Tablets\nGLIEMPAFLOZIN 3D 10 combines three established antidiabetic medicines with complementary mechanisms of action.\n\nTriple-combination formulation: Contains Empagliflozin, Sitagliptin, and Metformin Hydrochloride ER.\nMultiple glucose-control pathways: Targets different processes involved in blood glucose regulation.\nExtended-release metformin: Provides a formulation designed to release Metformin gradually over time.\nOral tablet dosage form: Allows administration according to the prescribed regimen.\nIndividualized diabetes management: May be considered when a healthcare professional determines that all three ingredients are appropriate.\nThe combination is not suitable for every person with diabetes. Treatment decisions should be based on individual medical needs and the approved product information.\n\nUses of GLIEMPAFLOZIN 3D 10\nGLIEMPAFLOZIN 3D 10 is intended for the management of type 2 diabetes mellitus, subject to its approved indications and the prescribing healthcare professional's assessment.\n\nType 2 diabetes is a chronic metabolic condition characterized by impaired insulin action and, in many patients, insufficient insulin production. Persistently elevated blood glucose can increase the risk of complications affecting the eyes, kidneys, nerves, heart, and blood vessels.\n\nThe three active ingredients in GLIEMPAFLOZIN 3D 10 address different aspects of glucose regulation. A healthcare professional may consider this combination when multiple medicines are required to achieve an individual's treatment goals and when the combination is clinically appropriate.\n\nThe medicine should be used as part of a comprehensive diabetes-management plan that may include balanced nutrition, regular physical activity, blood glucose monitoring, and routine medical assessments. It is not intended for the treatment of type 1 diabetes or diabetic ketoacidosis.\n\nHow Does GLIEMPAFLOZIN 3D 10 Work?\n1. Empagliflozin 10 mg\nEmpagliflozin belongs to the SGLT2 inhibitor class. It blocks a protein responsible for reabsorbing glucose filtered by the kidneys. This allows more glucose to be eliminated through urine, helping reduce blood glucose levels.\n\nEmpagliflozin has also demonstrated cardiovascular and kidney benefits in certain eligible patient populations. Whether these benefits apply to an individual depends on their clinical condition and the applicable prescribing information.\n\n2. Sitagliptin 100 mg\nSitagliptin inhibits the DPP-4 enzyme, which breaks down incretin hormones. By increasing incretin activity, Sitagliptin supports insulin release when blood glucose is elevated and helps regulate glucagon secretion. These actions contribute to blood glucose control.\n\n3. Metformin Hydrochloride ER 1000 mg\nMetformin primarily reduces glucose production in the liver and improves insulin sensitivity. The extended-release formulation is designed to release the medicine gradually over time.\n\nTogether, these ingredients target several pathways involved in type 2 diabetes. Their combined effectiveness and safety depend on appropriate prescribing, correct administration, and regular monitoring.\n\nPotential Benefits of GLIEMPAFLOZIN 3D 10\nWhen prescribed for an appropriate patient, GLIEMPAFLOZIN 3D 10 may offer the following treatment advantages:\n\nMultiple mechanisms of action: Combines three medicines that influence different aspects of glucose regulation.\nBlood glucose management: Helps improve glycemic control in eligible adults with type 2 diabetes.\nCombination therapy: May simplify a treatment regimen compared with taking the same ingredients as separate tablets.\nExtended-release component: Includes Metformin Hydrochloride ER for gradual drug release.\nPersonalized treatment options: May be considered when a healthcare professional determines that triple therapy is appropriate.\nIndividual outcomes vary, and the medicine does not replace a suitable diet, physical activity, or routine diabetes care.\n\nDirections for Use\nTake GLIEMPAFLOZIN 3D 10 only as prescribed by your healthcare professional.\n\nFollow the prescribed dose and administration schedule.\nTake the tablet with food if directed by the product labeling or your prescriber.\nSwallow the extended-release tablet whole unless the specific product instructions state otherwise. Do not crush, chew, or split it without professional guidance.\nDo not change the dose or stop treatment without consulting your prescriber.\nAttend recommended appointments for kidney-function assessment and blood glucose monitoring.\nIf you miss a dose, follow the official patient information or ask your healthcare professional or pharmacist what to do. Do not take an extra dose to compensate for a missed dose unless specifically instructed.\n\nPrecautions and Safety Information\nGLIEMPAFLOZIN 3D 10 is a prescription medicine and may not be suitable for everyone.\n\nKidney function: Kidney function should be assessed before and during treatment as appropriate. Metformin and Empagliflozin have important kidney-related prescribing considerations.\n\nDehydration: Empagliflozin increases glucose excretion through urine and may increase urination. Patients at risk of dehydration or low blood pressure should discuss appropriate precautions with their healthcare professional.\n\nGenital and urinary infections: Empagliflozin may increase the risk of genital fungal infections and can be associated with urinary tract infections.\n\nLactic acidosis: Metformin can rarely cause a serious condition called lactic acidosis. Risk may increase with significant kidney impairment, severe dehydration, certain acute illnesses, or excessive alcohol intake.\n\nPancreatitis: Pancreatitis has been reported in patients taking Sitagliptin. Severe, persistent abdominal pain requires prompt medical assessment.\n\nHypoglycemia: Low blood glucose may occur, particularly when the combination is used with insulin or insulin secretagogues such as sulfonylureas.\n\nInform your healthcare professional about existing medical conditions, all medicines you take, pregnancy or breastfeeding, planned surgery, prolonged fasting, and upcoming procedures involving iodinated contrast. Follow professional instructions about temporary medicine interruption during acute illness or other high-risk situations.\n\nSeek urgent medical care for severe abdominal pain, difficulty breathing, persistent vomiting, severe dehydration, or other serious symptoms.\n\nWhy Choose GLIEMPAFLOZIN 3D 10?\nGLIEMPAFLOZIN 3D 10 brings together Empagliflozin 10 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg in a triple-combination tablet intended for selected patients with type 2 diabetes.\n\nFor pharmaceutical websites, pharmacies, distributors, and healthcare professionals, clear information about composition, mechanism of action, potential uses, and precautions supports responsible product awareness.\n\nAlways refer to the approved product label for the exact composition, indications, dosage, contraindications, storage requirements, and instructions for use.\n\nConclusion\nGLIEMPAFLOZIN 3D 10 Tablets combine Empagliflozin 10 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg to target multiple pathways involved in blood glucose regulation. The combination may be appropriate for selected adults with type 2 diabetes under medical supervision.\n\nFor complete information about dosage, contraindications, warnings, storage, and approved indications, consult the official product packaging and prescribing information. Use this medicine only under the direction of a qualified healthcare professional.\n\nFrequently Asked Questions (FAQs)\n1. What is GLIEMPAFLOZIN 3D 10?\n\nGLIEMPAFLOZIN 3D 10 is a combination tablet containing Empagliflozin 10 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg.\n\n2. What is GLIEMPAFLOZIN 3D 10 used for?\n\nIt is intended for the management of type 2 diabetes mellitus in patients for whom this combination is considered appropriate by a healthcare professional.\n\n3. How does GLIEMPAFLOZIN 3D 10 work?\n\nEmpagliflozin increases urinary glucose excretion, Sitagliptin supports glucose-dependent insulin regulation, and Metformin reduces glucose production in the liver and improves insulin sensitivity.\n\n4. Can GLIEMPAFLOZIN 3D 10 replace diet and exercise?\n\nNo. Medication should be combined with an individualized diet, physical activity, and monitoring plan recommended by a healthcare professional.\n\n5. Is GLIEMPAFLOZIN 3D 10 suitable for everyone with diabetes?\n\nNo. Suitability depends on the type of diabetes, kidney function, other medical conditions, concurrent medicines, and approved prescribing information.\n\n",
"price": 210.0,
"discountamount": 147.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2505,
"imageuri": "https://productimages.withfloats.com/actual/6ad7470422551901df6e5493.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6ad7470422551901df6e5493.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-10-20T10:48:34.116Z",
"updatedon": "2026-10-20T10:48:34.116Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//empagliozin-10-mg-sitagliptin-100-mg-and-metformin-hydrochloride-1000-mg-er-tablets/2505",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "GLIEMPAFLOZIN 3D 10",
"category": "DIABETIC RANGE",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6ad7442bf24c5a4bbccf4b10",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Empagliflozin,Sitagliptin And Metformin Hydrochloride (ER) Tablets",
"description": "GLIEMPAFLOZIN 3D 25 is a combination pharmaceutical product containing Empagliflozin 25 mg, Sitagliptin 100 mg, and Metformin Hydrochloride Extended Release (ER) 1000 mg. This triple-combination formulation is intended for the management of type 2 diabetes mellitus in appropriate patients, as determined by a qualified healthcare professional.\n\nThe three active ingredients work through different mechanisms to help control blood glucose levels. Empagliflozin belongs to the sodium-glucose cotransporter 2 (SGLT2) inhibitor class, Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor, and Metformin is a biguanide antidiabetic medicine. Together, these ingredients target different pathways involved in glucose regulation.\n\nGLIEMPAFLOZIN 3D 25 provides a combination of three established antidiabetic agents in a single tablet. Its suitability depends on the patient's blood glucose levels, kidney function, current diabetes treatment, medical history, and the approved prescribing information.\n\nComposition of GLIEMPAFLOZIN 3D 25\nEach tablet contains the following stated active ingredients:\n\nEmpagliflozin 25 mg: An SGLT2 inhibitor that helps the kidneys remove glucose from the bloodstream through urine.\nSitagliptin 100 mg: A DPP-4 inhibitor that increases the activity of incretin hormones involved in glucose-dependent insulin release and glucagon regulation.\nMetformin Hydrochloride ER 1000 mg: An extended-release biguanide that primarily reduces glucose production in the liver and improves the body's response to insulin.\nThe exact formulation, excipients, administration instructions, and approved indications should be verified against the product packaging and official prescribing information.\n\nKey Features of GLIEMPAFLOZIN 3D 25\nGLIEMPAFLOZIN 3D 25 combines three antidiabetic ingredients with complementary mechanisms of action.\n\nTriple-combination formulation: Contains Empagliflozin, Sitagliptin, and Metformin Hydrochloride ER.\nMultiple glucose-control pathways: The ingredients act through different mechanisms involved in blood glucose regulation.\nExtended-release metformin: The ER formulation is designed to release metformin over an extended period.\nOral tablet dosage form: Provides oral administration according to the prescribed regimen.\nIndividualized diabetes management: May be considered by a healthcare professional when combination therapy is appropriate.\nThe benefits of this combination depend on the patient's clinical needs and the suitability of all three ingredients.\n\nUses of GLIEMPAFLOZIN 3D 25 Tablets\nGLIEMPAFLOZIN 3D 25 is intended for the management of type 2 diabetes mellitus, subject to the product's approved indications and the prescribing healthcare professional's judgment.\n\nType 2 diabetes is a chronic metabolic condition in which the body does not use insulin effectively or does not produce enough insulin to maintain healthy blood glucose levels. Long-term elevated blood glucose can increase the risk of complications affecting the eyes, kidneys, nerves, heart, and blood vessels.\n\nThe three medicines in GLIEMPAFLOZIN 3D 25 target different aspects of glucose regulation. A healthcare professional may consider a combination regimen when an individual's treatment goals are not adequately achieved with a simpler regimen or when the combination is otherwise clinically appropriate.\n\nThe medicine should be used alongside an individualized diabetes-management plan that may include a balanced diet, physical activity, glucose monitoring, and regular medical follow-up. It is not intended for the treatment of type 1 diabetes or diabetic ketoacidosis.\n\nHow Does GLIEMPAFLOZIN 3D 25 Work?\nThe three active ingredients contribute to blood glucose management through distinct mechanisms.\n\n1. Empagliflozin 25 mg\nEmpagliflozin inhibits SGLT2, a protein responsible for reabsorbing much of the glucose filtered by the kidneys. By reducing glucose reabsorption, it increases glucose excretion through urine and helps lower blood glucose levels.\n\nEmpagliflozin has also demonstrated cardiovascular and kidney benefits in certain eligible patient populations. These benefits depend on the patient's condition and the applicable prescribing information and should not be assumed to apply identically to every patient.\n\n2. Sitagliptin 100 mg\nSitagliptin inhibits the DPP-4 enzyme, which breaks down incretin hormones. Increasing incretin activity helps stimulate insulin release when blood glucose is elevated and reduces glucagon secretion when appropriate. This helps regulate glucose levels, particularly after meals.\n\n3. Metformin Hydrochloride ER 1000 mg\nMetformin primarily decreases glucose production in the liver and improves insulin sensitivity. The extended-release formulation is designed to release the medicine gradually over time.\n\nBy combining these mechanisms, GLIEMPAFLOZIN 3D 25 targets several pathways involved in type 2 diabetes. Its overall effectiveness and safety depend on appropriate patient selection, dosing, and ongoing monitoring.\n\nPotential Benefits of GLIEMPAFLOZIN 3D 25\nWhen prescribed for an appropriate patient, this combination may offer the following treatment advantages:\n\nMultiple mechanisms of action: Addresses glucose regulation through three different pharmacological pathways.\nBlood glucose management: Helps improve glycemic control in eligible adults with type 2 diabetes.\nOral combination therapy: Combines three medicines in one tablet, which may simplify a prescribed regimen compared with taking each ingredient separately.\nExtended-release component: Includes Metformin Hydrochloride ER for gradual drug release.\nIndividualized treatment options: May be considered when a healthcare professional determines that all three ingredients are appropriate.\nThese potential advantages do not guarantee a particular result. Treatment effectiveness depends on adherence, diet, physical activity, individual health status, and medical supervision.\n\nDirections for Use\nGLIEMPAFLOZIN 3D 25 should be taken only as prescribed by a qualified healthcare professional.\n\nFollow the prescribed dose and administration schedule.\nTake the tablet with food if directed by the product labeling or prescriber.\nSwallow the extended-release tablet whole unless the specific product instructions state otherwise. Do not crush, chew, or split it without professional guidance.\nDo not change the dose or discontinue treatment without consulting your prescriber.\nAttend recommended appointments for blood glucose monitoring and kidney-function assessment.\nIf a dose is missed, follow the official patient information or ask your healthcare professional or pharmacist for advice. Do not take an extra dose to compensate for a missed dose unless specifically instructed.\n\nPrecautions and Safety Information\nGLIEMPAFLOZIN 3D 25 is a prescription medicine and is not suitable for everyone.\n\nKidney function: Kidney function should be assessed before and during treatment as appropriate. Metformin and Empagliflozin have important renal considerations, and the combination may be unsuitable at certain levels of kidney impairment.\n\nDehydration: Empagliflozin increases glucose excretion through urine and may increase urination. Patients should discuss dehydration risk, low blood pressure, and fluid intake with their healthcare professional.\n\nGenital and urinary infections: Empagliflozin can increase the risk of genital fungal infections and may be associated with urinary tract infections.\n\nLactic acidosis: Metformin can rarely cause a serious condition called lactic acidosis. Risk may increase with significant kidney impairment, severe dehydration, certain acute illnesses, excessive alcohol intake, or other predisposing conditions.\n\nPancreatitis: Pancreatitis has been reported in patients taking Sitagliptin. Severe, persistent abdominal pain requires prompt medical assessment.\n\nLow blood glucose: The risk of hypoglycemia may increase when this combination is used with insulin or insulin secretagogues, such as sulfonylureas.\n\nInform your healthcare professional about existing medical conditions, all medicines you take, pregnancy or breastfeeding, planned surgery, prolonged fasting, or an upcoming medical procedure involving iodinated contrast. Follow professional instructions about temporary medicine interruption during acute illness or other high-risk situations.\n\nSeek urgent medical care for severe abdominal pain, difficulty breathing, unusual weakness, persistent vomiting, severe dehydration, or other serious symptoms.\n\nWhy Choose GLIEMPAFLOZIN 3D 25?\nGLIEMPAFLOZIN 3D 25 brings together Empagliflozin, Sitagliptin, and Metformin Hydrochloride ER in a triple-combination tablet designed for the management of type 2 diabetes in appropriately selected patients.\n\nFor pharmaceutical product catalogues, distributors, pharmacies, and healthcare professionals, accurate information about the composition, mechanism of action, approved indications, and safety profile supports responsible product awareness.\n\nTreatment decisions should always be based on the patient's medical assessment and the approved product information.\n\nConclusion\nGLIEMPAFLOZIN 3D 25 Tablets combine Empagliflozin 25 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg to target multiple pathways involved in blood glucose regulation. This combination may be appropriate for selected adults with type 2 diabetes under medical supervision.\n\nFor complete information about dosage, contraindications, warnings, storage, and approved indications, consult the official product packaging and prescribing information. Use this medicine only under the direction of a qualified healthcare professional.\n\nFrequently Asked Questions (FAQs)\n1. What is GLIEMPAFLOZIN 3D 25?\n\nGLIEMPAFLOZIN 3D 25 is a combination tablet containing Empagliflozin 25 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg.\n\n2. What is GLIEMPAFLOZIN 3D 25 used for?\n\nIt is intended for the management of type 2 diabetes mellitus in patients for whom the combination is considered appropriate by a healthcare professional.\n\n3. How does GLIEMPAFLOZIN 3D 25 work?\n\nEmpagliflozin increases urinary glucose excretion, Sitagliptin supports glucose-dependent insulin regulation, and Metformin reduces glucose production in the liver and improves insulin sensitivity.\n\n4. Can GLIEMPAFLOZIN 3D 25 replace diet and exercise?\n\nNo. Medication should be combined with an individualized diet, physical activity, and monitoring plan as recommended by a healthcare professional.\n\n5. Is GLIEMPAFLOZIN 3D 25 suitable for everyone with diabetes?\n\nNo. Its suitability depends on the type of diabetes, kidney function, other medical conditions, concurrent medicines, and the approved prescribing information.",
"price": 230.0,
"discountamount": 69.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2504,
"imageuri": "https://productimages.withfloats.com/actual/6ad7442d6e565c5fe6e5b7cb.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6ad7442d6e565c5fe6e5b7cb.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-10-20T10:36:27.325Z",
"updatedon": "2026-10-20T10:36:27.325Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//empagliflozin-sitagliptin-and-metformin-hydrochloride-er-tablets/2504",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "GLIEMPAFLOZIN 3D 25",
"category": "DIABETIC RANGE",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6a6dec4d7747964c2eea9a0f",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Metoprolol Succinate & Hydrochlorthiazide Extended Release Tablets",
"description": "METAPROLATE H 50/12.5 is a premium antihypertensive medication formulated with Metoprolol Succinate Extended Release 50 mg and Hydrochlorothiazide 12.5 mg. This dual-action combination is intended for the treatment of hypertension (high blood pressure) in adults who require combination therapy for better blood pressure control. By combining two well-established medicines with complementary mechanisms of action, the formulation helps support long-term cardiovascular health while offering the convenience of once-daily dosing.\n\nManufactured in GMP-certified facilities using high-quality pharmaceutical ingredients, METAPROLATE H 50/12.5 is produced under rigorous quality assurance protocols to ensure safety, efficacy, and batch-to-batch consistency. The extended-release technology allows a gradual release of Metoprolol throughout the day, providing sustained therapeutic effects and helping maintain stable blood pressure levels.\n\nComposition\n\nBrand Name: METAPROLATE H 50/12.5\n\nGeneric Name: Metoprolol Succinate Extended Release & Hydrochlorothiazide Tablets\n\nEach Extended Release Tablet Contains:\n\nMetoprolol Succinate Extended Release – 50 mg\nHydrochlorothiazide – 12.5 mg\n\nDosage Form: Extended Release Tablets\n\nTherapeutic Category: Antihypertensive Medication\n\nWhat is METAPROLATE H 50/12.5?\n\nMETAPROLATE H 50/12.5 combines a beta-blocker and a thiazide diuretic to provide comprehensive blood pressure management.\n\nMetoprolol Succinate selectively blocks beta-1 receptors in the heart, reducing heart rate and decreasing the workload on the cardiovascular system. Hydrochlorothiazide acts as a diuretic by helping the body eliminate excess sodium and water through urine, lowering blood volume and contributing to reduced blood pressure.\n\nTogether, these medicines offer a complementary approach to hypertension treatment and may help lower the risk of complications associated with persistently elevated blood pressure, including stroke, heart attack, and kidney damage, when used according to medical advice.\n\nUses of METAPROLATE H 50/12.5\n\nHealthcare professionals may prescribe METAPROLATE H 50/12.5 for:\n\nManagement of essential hypertension\nPatients requiring combination antihypertensive therapy\nLong-term maintenance of healthy blood pressure levels\nReducing cardiovascular risks associated with uncontrolled hypertension\nSupporting comprehensive blood pressure management alongside lifestyle modifications\n\nThis medicine should always be used under the supervision of a qualified healthcare professional.\n\nBenefits of METAPROLATE H 50/12.5\nDual-Action Blood Pressure Control\n\nThe combination of Metoprolol Succinate and Hydrochlorothiazide addresses hypertension through two different therapeutic pathways, providing effective blood pressure reduction.\n\nSustained Drug Release\n\nThe extended-release formulation delivers Metoprolol gradually over 24 hours, helping maintain stable therapeutic levels and consistent blood pressure control.\n\nConvenient Once-Daily Administration\n\nA single daily dose simplifies long-term treatment and may improve patient adherence to prescribed therapy.\n\nSupports Cardiovascular Health\n\nMaintaining optimal blood pressure with appropriate treatment can help reduce the likelihood of serious cardiovascular complications over time.\n\nManufactured to High Quality Standards\n\nEvery batch is produced using premium pharmaceutical ingredients under strict GMP guidelines, ensuring reliable quality, safety, and consistency.\n\nHow METAPROLATE H 50/12.5 Works\n\nThe effectiveness of METAPROLATE H 50/12.5 is based on the complementary actions of its two active ingredients.\n\nMetoprolol Succinate works by selectively blocking beta-1 adrenergic receptors in the heart, which helps:\n\nSlow the heart rate\nReduce the force of cardiac contractions\nDecrease oxygen demand by the heart\nLower blood pressure\n\nHydrochlorothiazide works by promoting the removal of excess salt and water from the body through the kidneys. This helps:\n\nReduce circulating blood volume\nMinimize fluid retention\nLower blood pressure\nImprove overall cardiovascular function\n\nTogether, these mechanisms contribute to effective and sustained blood pressure management.\n\nDosage and Administration\n\nTake METAPROLATE H 50/12.5 exactly as prescribed by your physician.\n\nGeneral recommendations include:\n\nTake one tablet daily or as directed by your healthcare provider.\nSwallow the extended-release tablet whole with water.\nDo not crush, chew, or split the tablet unless specifically instructed.\nIt may be taken with or without food according to your doctor's advice.\nTake the medication at the same time each day to maintain consistent therapeutic levels.\nContinue treatment as prescribed, even if your blood pressure is well controlled, unless your doctor advises otherwise.\nPossible Side Effects\n\nAs with any prescription medicine, some individuals may experience side effects, although many people tolerate the medication well.\n\nCommonly reported side effects include:\n\nDizziness\nTiredness or fatigue\nSlow heartbeat\nHeadache\nIncreased urination\nNausea\nLow blood pressure\nChanges in electrolyte levels\n\nSeek immediate medical attention if you experience severe allergic reactions, breathing difficulties, fainting, persistent chest pain, or any other serious symptoms.\n\nConsult your healthcare provider if any side effect persists or becomes troublesome.\n\nPrecautions and Warnings\n\nBefore starting METAPROLATE H 50/12.5, inform your healthcare provider if you have:\n\nHeart rhythm abnormalities\nHeart failure\nAsthma or chronic respiratory disorders\nDiabetes mellitus\nKidney or liver impairment\nGout\nElectrolyte imbalance\nThyroid disorders\nAllergy to Metoprolol, Hydrochlorothiazide, sulfonamide-derived medicines, or any ingredient in this product\n\nRegular monitoring of blood pressure, heart rate, kidney function, and electrolyte levels may be recommended during treatment.\n\nStorage Instructions\n\nTo maintain product quality:\n\nStore in a cool and dry place.\nProtect from excessive heat, moisture, and direct sunlight.\nKeep the tablets in their original packaging until use.\nStore at the temperature indicated on the product label.\nKeep out of the reach of children.\nWhy Choose METAPROLATE H 50/12.5?\n\nMETAPROLATE H 50/12.5 is formulated to provide dependable blood pressure management with the convenience of a once-daily extended-release dosage form. Manufactured according to stringent pharmaceutical quality standards, it combines two trusted antihypertensive agents in a single tablet, supporting improved treatment adherence and long-term cardiovascular care.\n\nKey Advantages\n\nExtended-release formulation for sustained therapeutic action\nCombination of two proven antihypertensive medicines\nConvenient once-daily dosing\nHigh-quality manufacturing with strict quality assurance\nReliable efficacy and consistent product performance\nSuitable for long-term hypertension management under medical supervision\nFrequently Asked Questions (FAQs)\nWhat is METAPROLATE H 50/12.5 prescribed for?\n\nIt is prescribed for the treatment of high blood pressure in adults who require combination antihypertensive therapy.\n\nHow does the extended-release formulation benefit patients?\n\nThe extended-release technology gradually releases Metoprolol throughout the day, helping maintain consistent blood levels and prolonged blood pressure control.\n\nCan I discontinue METAPROLATE H 50/12.5 on my own?\n\nNo. Beta-blockers should not be stopped suddenly, as abrupt discontinuation may increase cardiovascular risk. Always consult your healthcare provider before making any changes to your treatment.\n\nCan this medicine be used with other antihypertensive medications?\n\nYour doctor will determine whether additional blood pressure medicines are necessary based on your medical condition and treatment goals.\n\nHow long should treatment continue?\n\nHypertension is often a lifelong condition requiring continuous management. Continue taking METAPROLATE H 50/12.5 for the duration recommended by your healthcare professional, along with appropriate lifestyle modifications and regular medical follow-up.",
"price": 248.0,
"discountamount": 75.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2488,
"imageuri": "https://productimages.withfloats.com/actual/6a6dec4fc0246085c8f72513.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6a6dec4fc0246085c8f72513.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-08-01T12:53:33.409Z",
"updatedon": "2026-08-01T12:53:33.409Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//metoprolol-succinate-hydrochlorthiazide-extended-release-tablets/2488",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "METAPROLATE H 50/12.5",
"category": "CARDIOLOGYRANGE",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6a46068a3a7982b6888cdba1",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Polyethylene Glycol 400 & Propylene Glycol Eye Drops",
"description": "Carboxymethylcellulose (CMC) Eye Drops IP 0.5% w/v is an over-the-counter lubricant eye drop used to relieve dryness, burning, and irritation caused by insufficient tear production. It works by coating the eye's surface with a moisture-retaining film, is safe for regular daily use, and is suitable for adults experiencing dry eye syndrome, screen-related eye strain, or contact lens discomfort.\n\nWhat Is Carboxymethylcellulose Eye Drops IP 0.5% w/v?\n\nCarboxymethylcellulose Sodium Eye Drops IP 0.5% w/v is a lubricating eye drop (artificial tear) formulated to relieve symptoms of dry eye — including burning, stinging, grittiness, and light sensitivity caused by inadequate natural tear film. It is manufactured to Indian Pharmacopoeia (IP) standards and is classified as an over-the-counter (OTC) ophthalmic lubricant, meaning it does not require a prescription for routine dry-eye relief, though a doctor's guidance is recommended for chronic or unexplained symptoms.\n\nHow It Works\n\nCarboxymethylcellulose is a viscosity-enhancing, water-retentive polymer that mimics the mucin and aqueous layers of the natural tear film.\n\n\nCoats the ocular surface – forms a smooth, even film across the cornea and conjunctiva immediately after application.\nRetains moisture – its water-binding structure slows tear evaporation, keeping the eye surface hydrated for longer.\nReduces friction – lubricates the eyelid-cornea interface, easing the grating or gritty sensation typical of dry eye.\nSupports healing – a stable tear film reduces micro-abrasion of surface cells, helping symptomatic recovery with regular use.\nExtends comfort duration – the 0.5% concentration is calibrated to balance lubrication strength with comfortable, non-blurring application.\n\n\nClinical Indications\n\nConditionHow CMC 0.5% HelpsDry Eye Syndrome (Keratoconjunctivitis Sicca)Restores moisture balance, relieves burning and grittinessDigital Eye Strain (screen-related dryness)Rehydrates surface dried by reduced blink rateContact Lens–Related DrynessLubricates lens-eye interface, improves comfortPost-LASIK/Ocular Surgery DrynessSupports surface comfort during recovery (as advised by ophthalmologist)Environmental Irritation (dust, AC, wind exposure)Flushes and cushions irritants, restores comfort\n\nDosage & How to Use\n\nParameterRecommendationStandard Dose1–2 drops in the affected eye(s)Frequency3–4 times daily, or as needed for symptom reliefMaximum UseCan be used more frequently under doctor guidance for severe drynessApplication MethodTilt head back, pull lower eyelid down, instill drop without touching tip to eyeContact Lens UseRemove lenses before application unless the product is lens-compatible; reinsert after 15 minutesStorageStore below 25°C, away from direct sunlight; discard 4 weeks after opening\n\nPrecautions\n\n\nDo not touch the dropper tip to the eye, eyelid, or any surface to avoid contamination.\nDiscontinue and consult a doctor if eye pain, vision change, redness, or irritation persists beyond 72 hours.\nWait at least 5–10 minutes between this and any other eye medication.\nNot a substitute for treating underlying causes of chronic dry eye (e.g., blepharitis, Sjögren's syndrome) — seek medical evaluation for persistent cases.\nSafety in pregnancy and breastfeeding should be confirmed with a physician, though topical ocular absorption is minimal.\nKeep out of reach of children.\n\n\nPossible Side Effects\n\nMost users tolerate carboxymethylcellulose eye drops well. Reported effects are typically mild and transient:\n\n\nTemporary blurred vision immediately after application\nMild stinging or watering on instillation\nEye irritation or redness (uncommon)\nRare allergic reaction (itching, swelling, rash) — discontinue and seek medical advice if this occurs\n\n\nSerious side effects are rare. Seek immediate medical attention for severe eye pain, sudden vision loss, or signs of infection (discharge, swelling, fever).\n\nComparison: CMC 0.5% vs. Other Lubricant Eye Drops\n\nIngredientViscosityBest ForPrescription NeededCarboxymethylcellulose 0.5%MediumGeneral dry eye, daily useNo (OTC)Sodium Hyaluronate 0.1–0.3%Low–MediumMild dryness, contact lens comfortNo (OTC)Carbomer Gel 0.2%HighSevere/nighttime drynessNo (OTC)Polyethylene Glycol + Propylene GlycolMediumCombination dryness reliefNo (OTC)Hydroxypropyl Methylcellulose 0.3%MediumShort-term irritation reliefNo (OTC)\n\nKey Statistics\n\nStatisticData PointSourceGlobal dry eye disease prevalence5–50% depending on population and diagnostic criteriaTear Film & Ocular Surface Society (TFOS DEWS II)India dry eye prevalence in urban adultsApprox. 32–40% in screen-exposed populationsIndian Journal of Ophthalmology, published studiesCMC as first-line OTC therapyRecommended as first-line lubricant in dry eye management guidelinesTFOS DEWS II Management ReportAdults reporting digital eye strain symptomsOver 60% among regular screen usersAmerican Optometric Association survey data\n\nExpert Insight\n\n[Insert verified ophthalmologist or optometrist commentary here — Claude has not fabricated a quote. Recommend sourcing a short, attributable statement from a Steris Healthcare medical advisor or a cited clinical reference before publishing.]\n\nConclusion\n\nCarboxymethylcellulose Eye Drops IP 0.5% w/v is a reliable, first-line OTC lubricant for anyone dealing with dry, tired, or irritated eyes — whether the cause is long screen hours, contact lens wear, environmental exposure, or general dry eye syndrome. Its moisture-retentive formula coats and hydrates the eye surface on contact, offering fast, non-prescription relief suitable for daily use. While generally safe and well-tolerated, persistent or worsening symptoms should always be evaluated by an eye care professional. For consistent, pharmacopoeia-grade quality, choose a WHO-GMP certified formulation and buy online through a trusted pharmaceutical source.\n\n\nHigh-Ranking FAQs (Google Search & Voice Search Optimized)\n\n1. What is carboxymethylcellulose eye drops IP 0.5% w/v used for?\nIt is used to relieve dry, irritated, or burning eyes caused by insufficient natural tear production, screen use, contact lenses, or environmental exposure. It works as an artificial tear that lubricates and hydrates the eye surface.\n\n2. How often can I use carboxymethylcellulose eye drops?\nMost people use 1–2 drops, 3–4 times a day, or as needed for comfort. For severe dryness, frequency can be increased under a doctor's guidance, since this OTC lubricant has a strong safety profile for repeated daily use.\n\n3. Can I use carboxymethylcellulose eye drops with contact lenses?\nYes, but check the product label first. Many formulations require lens removal before application, with reinsertion after about 15 minutes, unless the specific product is labeled as contact-lens compatible.\n\n4. Is carboxymethylcellulose 0.5% safe for daily long-term use?\nYes, it is considered safe for regular daily use as a lubricant, and is often recommended as a first-line therapy for chronic dry eye. Persistent symptoms despite regular use should still be discussed with an eye specialist.\n\n5. What is the difference between carboxymethylcellulose and hyaluronic acid eye drops?\nCarboxymethylcellulose offers medium viscosity and longer-lasting lubrication, while sodium hyaluronate drops are typically lighter and better suited for mild dryness or lens comfort. Both are OTC options; choice depends on symptom severity.\n\n6. Are there side effects of carboxymethylcellulose eye drops?\nSide effects are generally mild, such as temporary blurred vision or slight stinging right after application. Serious reactions are rare, but persistent redness, pain, or vision changes warrant medical attention.\n\n7. How long does it take for carboxymethylcellulose eye drops to work?\nRelief is typically immediate to within a few minutes of application, as the drop forms a lubricating film over the eye surface right away. Full symptom control with consistent daily use may take a few days.\n\n8. Can pregnant or breastfeeding women use carboxymethylcellulose eye drops?\nTopical ocular absorption is minimal, and it's generally considered low-risk, but pregnant or breastfeeding women should confirm use with their doctor before starting any eye medication.",
"price": 379.0,
"discountamount": 113.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2464,
"imageuri": "https://productimages.withfloats.com/actual/6a46068dc94d045c2e16dd26.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6a46068dc94d045c2e16dd26.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-07-02T06:34:50.994Z",
"updatedon": "2026-07-02T06:34:50.994Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//polyethylene-glycol-400-propylene-glycol-eye-drops/2464",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "CIPVISION PEG",
"category": "Opthalmology Range",
"tags": [
"polyethylene glycol 400 & propylene glycol eye drops",
"polyethylene glycol 400 & propylene glycol eye drops uses"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
}
],
"hasmoreitems": false,
"isapirequest": false,
"totalresults": 27,
"query": null,
"floatingpoint": null
}